Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261905 · ClinicalTrials.gov registry record · Phase 1
Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT06261905 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 5 participants.
The verdict
NCT06261905, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The research team is investigating Opioid Use Disorder (OUD), a disorder characterized by dysregulated dopaminergic tone, to evaluate the mechanisms of adjunctive treatment with calcitriol. The investigators will recruit 12 subjects with OUD and 12 healthy subjects to participate in a double-blind, randomized study design where subjects will complete up to 2 Positron Emission Tomography (PET) scans using \[11C\]-PHNO. The investigators will compare subjects in differences between their own study days and in differences between healthy control subjects and subjects with OUD.
Interventions
- OTHER Placebo Control
- DIETARY_SUPPLEMENT Calcitriol
- PROCEDURE PET Scan
- DRUG [11C]-PHNO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-03-13 |
| Est. Completion | 2025-02-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06261905
The ClinicalTrials.gov registry entry for NCT06261905 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo Control is the first listed.
NCT06261905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06261905 about?
NCT06261905 is a clinical study titled "Vitamin D in OUD: Exploration of Alterations on the Dopamine D2/D3 Receptor System". The research team is investigating Opioid Use Disorder (OUD), a disorder characterized by dysregulated dopaminergic tone, to evaluate the mechanisms of adjunctive treatment with calcitriol. The investigators will recruit 12 subjects with OUD and 12 healthy subjects to participate in a double-blind, ...
What is the current status of trial NCT06261905?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2024-03-13. Estimated completion is 2025-02-18.
What interventions are being tested in trial NCT06261905?
The interventions under investigation include: Placebo Control (OTHER), Calcitriol (DIETARY_SUPPLEMENT), PET Scan (PROCEDURE), [11C]-PHNO (DRUG).
Who is sponsoring clinical trial NCT06261905?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.